Abstract Background Empagliflozin has been reported to protect endothelial cell function. regardless of diabetes status. However. the role of empagliflozin in microvascular protection during myocardial ischemia reperfusion injury (I/R) has not been fully understood. https://www.roneverhart.com/MagnaFlow-California-Grade-CARB-Compliant-Direct-Fit-Catalytic-Converter-6561416/